Reversible fetal hydrops associated with indomethacin use

Obstet Gynecol. 1997 Oct;90(4 Pt 2):676-8. doi: 10.1016/s0029-7844(97)00392-x.

Abstract

Background: Ductus arteriosus constriction is a known complication of exposure to indomethacin in utero. Nonimmune hydrops associated with indomethacin use has been reported in only six cases, all twins over 32 weeks' gestation.

Case: We present a case of fetal hydrops associated with tricuspid regurgitation and ductal constriction developing within 30 hours of instituting indomethacin tocolysis in a 28-week singleton gestation. Discontinuation of indomethacin resulted in partial resolution of these findings 72 hours later. A normal infant was delivered subsequently.

Conclusion: Ultrasonographic screening for signs of constriction of the ductus arteriosus should be done within 48 hours of instituting indomethacin therapy at any gestational age.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Ductus Arteriosus / drug effects
  • Female
  • Humans
  • Hydrops Fetalis / chemically induced*
  • Hydrops Fetalis / diagnostic imaging
  • Indomethacin / adverse effects*
  • Pregnancy
  • Time Factors
  • Tocolytic Agents / adverse effects*
  • Tricuspid Valve Insufficiency / chemically induced
  • Ultrasonography, Prenatal

Substances

  • Tocolytic Agents
  • Indomethacin